---
title: Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation
date: '2023-07-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37502699/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230728180744&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: The prognosis for recurrent IDH-wt GBM after re-irradiation
  is poor. Patients who are amenable and able to undergo re-resection may have a favorable
  OS. A second course of radiotherapy with a moderate cumulative EQD2 and small- to
  medium-sized planning target volumes appeared safe regarding the occurrence of radiation
  ...'
disable_comments: true
---
CONCLUSION: The prognosis for recurrent IDH-wt GBM after re-irradiation is poor. Patients who are amenable and able to undergo re-resection may have a favorable OS. A second course of radiotherapy with a moderate cumulative EQD2 and small- to medium-sized planning target volumes appeared safe regarding the occurrence of radiation ...